| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Malik Fady Ibraham | EVP Research & Development | 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO | /s/ John O. Faurescu, attorney-in-fact for Dr. Malik | 18 Mar 2026 | 0001551778 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYTK | Common Stock | Sale | $474,577 | -7,636 | -4.6% | $62.15 | 158,299 | 17 Mar 2026 | Direct | F1 |
| transaction | CYTK | Common Stock | Sale | $273,274 | -4,397 | -2.8% | $62.15 | 153,902 | 17 Mar 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting. |
| F2 | Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting. |